logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

GREENTOWN SER (02869) spent 7.6277 million Hong Kong dollars on January 10 to repurchase 2 million shares.

date
17:19 10/01/2025
avatar
GMT Eight
Green City Services (02869) issued a statement, announcing that the company will invest 7.6277 million Hong Kong dollars in a project on January 10, 2025.
Greentown Real Estate Group (SEHK: 02869) announced that on January 10, 2025, the company will spend 7.6277 million Hong Kong dollars to repurchase 2 million shares at a repurchase price of HK$3.73-3.92 per share.
Related Articles
HK Stock
CSTONE PHARMA-B(02616): Pujihua (Pulatiene Capsules) has been included in the 2025 National Medical Insurance Catalogue.
HK Stock
XUANZHUBIO-B(02575): Innovative drug Anjiuwei successfully renewed to be included in the National Basic Medical Insurance Drug Catalog for 2025.
HK Stock
XUANZHUBIO-B(02575): The innovative drug Xuan Yuening has been included in the 2025 National Basic Medical Insurance Catalog for the first time.
CSTONE PHARMA-B(02616): Pujihua (Pulatiene Capsules) has been included in the 2025 National Medical Insurance Catalogue.
HK Stock
XUANZHUBIO-B(02575): Innovative drug Anjiuwei successfully renewed to be included in the National Basic Medical Insurance Drug Catalog for 2025.
HK Stock
XUANZHUBIO-B(02575): The innovative drug Xuan Yuening has been included in the 2025 National Basic Medical Insurance Catalog for the first time.
HK Stock
RECOMMEND
Stella McCartney and H&M Reunite to Advance Sustainable Fashion in 2026
Stella McCartney and H&M Reunite to Advance Sustainable Fashion in 2026
icon
04/12/2025
Tariff Reductions Deliver Significant Tailwind To Hyundai And GM
Tariff Reductions Deliver Significant Tailwind To Hyundai And GM
icon
04/12/2025
Celebrity Campaigns Ignite a New Denim Battle Among Major Retailers
Celebrity Campaigns Ignite a New Denim Battle Among Major Retailers
icon
04/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.